• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchBarinthus Biotherapeutics
    Picture of Barinthus Biotherapeutics logo

    BRNS — Barinthus Biotherapeutics News Story

    $0.740.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $30.23m
    • Enterprise Value
      -$29.00m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BRNS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BRNS Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:01 PM

    Picture of Barinthus Biotherapeutics logoBarinthus Biotherapeutics
    13/05/2022 19:01
    NASDAQ TRADE HALT  VACC.O  VOLATILITY TRADING PAUSE AT 02:01 PM
    

    Recent news on Barinthus Biotherapeutics

    See all news
    • Brief: Barinthus Bio Provides Update On Proposed Combination With Clywedog Therapeutics

      24/08/2026 23:58
    • Brief: Barinthus Biotherapeutics PLC Appoints Douglas Swirsky As CFO And Principal Accounting Officer Effective May 1, 2026

      22/04/2026 23:03
    • Brief: Barinthus Bio Announces Update On Phase 1 AVALON Clinical Trial Of VTP-1000 For The Treatment Of Celiac Disease

      10/12/2025 13:05
    • Brief: Barinthus Bio Reports Second Quarter 2025 Financial Results And Updates On Corporate Developments

      07/08/2025 13:16
    • Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing

      07/05/2025 13:20

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.